Jordana Jampel

DocwireNews

Using systematic review and meta-analysis, a group of researchers aimed to examine the pooled accuracy, sensitivity, and specificity of artificial intelligence (AI)–assisted cervical cytology screening and colposcopy for cervical intraepithelial neoplasia and cervical cancer screening. Results were <a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00571-6/fulltext">published</a> in EClinicalMedicine.
The researchers searched PubMed, Embase, and Cochrane Library databases for studies published between January 1, 1986, and August 31, 2024; 77 studies met the eligibility criteria after a full-text review. The performances of AI and experienced colposcopists were assessed via the area under the receiver operating characteristic curve in terms of sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) through random effects models.
Pooled diagnostic parameters of AI-assisted cervical cytology via Pap smear showed:
<ul>
<li>94% accuracy (95% CI, 92-96)</li>
<li>95% sensitivity (95% CI, 91-98)</li>
<li>94% specificity (95% CI, 89-97)</li>
<li>88% PPV (95% CI, 78-96)</li>
<li>95% NPV (95% CI, 89-99)</li>
</ul>
For AI-assisted cervical cytology via ThinPrep Pap test, pooled results showed:
<ul>
<li>90% accuracy (95% CI, 85-94)</li>
<li>97% sensitivity (95% CI, 95-99)</li>
<li>94% specificity (95% CI, 85-98)</li>
<li>84% PPV (95% CI, 64-98)</li>
<li>96% NPV (95% CI, 94-98)</li>
</ul>
In addition to the primary analysis, subgroup analyses of multiple diagnostic performance metrics in high-income versus low- and middle-income countries were conducted and revealed that for AI-assisted cervical cytology diagnosis, certain performance indicators were superior in high-income countries to those in low- and middle-income countries. Compared with experienced colposcopists, AI demonstrated superior accuracy (odds ratio, 1.75; 95% CI, 1.33-2.31; P&lt;.0001; I2=93%).
“These results underscore the potential and practical value of AI in preventing and enabling early diagnosis of cervical cancer. Further research should support the development of AI for cervical cancer screening, including in low- and middle-income countries with limited resources,” the researchers concluded.
Source
<a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00571-6/fulltext">EClinicalMedicine</a>

Using systematic review and meta-analysis, a group of researchers aimed to examine the pooled accuracy, sensitivity, and specificity of artificial intelligence (AI)–assisted cervical cytology screening and colposcopy for cervical intraepithelial neoplasia and cervical cancer screening. Results were <a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00571-6/fulltext">published</a> in EClinicalMedicine.The researchers searched PubMed, Embase, and Cochrane Library databases for studies published between January 1, 1986, and August 31, 2024; 77 studies met the eligibility criteria after a full-text review. The performances of AI and experienced colposcopists were assessed via the area under the receiver operating characteristic curve in terms of sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) through random effects models.Pooled diagnostic parameters of AI-assisted cervical cytology via Pap smear showed:<ul>
<li>94% accuracy (95% CI, 92-96)</li>
<li>95% sensitivity (95% CI, 91-98)</li>
<li>94% specificity (95% CI, 89-97)</li>
<li>88% PPV (95% CI, 78-96)</li>
<li>95% NPV (95% CI, 89-99)</li>
</ul>For AI-assisted cervical cytology via ThinPrep Pap test, pooled results showed:<ul>
<li>90% accuracy (95% CI, 85-94)</li>
<li>97% sensitivity (95% CI, 95-99)</li>
<li>94% specificity (95% CI, 85-98)</li>
<li>84% PPV (95% CI, 64-98)</li>
<li>96% NPV (95% CI, 94-98)</li>
</ul>In addition to the primary analysis, subgroup analyses of multiple diagnostic performance metrics in high-income versus low- and middle-income countries were conducted and revealed that for AI-assisted cervical cytology diagnosis, certain performance indicators were superior in high-income countries to those in low- and middle-income countries. Compared with experienced colposcopists, AI demonstrated superior accuracy (odds ratio, 1.75; 95% CI, 1.33-2.31; P&lt;.0001; I2=93%).“These results underscore the potential and practical value of AI in preventing and enabling early diagnosis of cervical cancer. Further research should support the development of AI for cervical cancer screening, including in low- and middle-income countries with limited resources,” the researchers concluded.Source<a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00571-6/fulltext">EClinicalMedicine</a>

Paternal Distress Linked to Child Development Delays

Neurology

Comparing Diets for IBS Relief: Mediterranean Versus Low-FODMAP

Gastroenterology

Anne Marie Morse, DO

Wearable Sleep Tech: Promise, Pitfalls, and Personalization

Sleep Disorders

Latest News

Accuracy, Specificity of Artificial Intelligence for Diagnosing Cervical Intraepithelial Neoplasia and Cancer

Cervical Cancer

Subgroup analyses of multiple diagnostic performance metrics in high vs low-income communities were also performed. 

Accuracy, Specificity of Artificial Intelligence for Diagnosing Cervical Neoplasia and Cancer

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Diabetes

Obesity

Metabolic Care Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe